Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
about
Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinomaEsophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities.Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugateCancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.A systematic analysis of human lipocalin family and its expression in esophageal carcinoma.A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers.Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesionThe characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.Novel diagnostic and prognostic biomarkers in esophageal cancer.In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer.Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.Genome-Wide Analysis of Barrett's Adenocarcinoma. A First Step Towards Identifying Patients at Risk and Developing Therapeutic Paths.Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data.MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.Long non-coding RNA AK096174 promotes cell proliferation and invasion in gastric cancer by regulating WDR66 expressionMetastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
P2860
Q33589032-D2750E1D-1718-46EB-9FEC-D31F518974D5Q33612658-55089393-38E0-4237-9AA1-BD764B7AB19BQ33648759-B613BE71-5116-44CF-B9DA-4BE9C043978AQ35035236-DC44CCF8-31AA-44DF-B726-4F6A4F0794ACQ35804193-60CFF3AC-24DF-49E7-A4AE-0502F8F7F6F2Q35881485-24AA12E6-1166-416A-A690-6E61F9003356Q36296731-D4A7DC0B-B407-49D2-BA32-EFBE556B6008Q36528097-413AD9E5-34D4-437C-A11F-711B4AEF4AA0Q37227732-215D708F-97E1-4A77-BAA9-4EC0F06E8CA7Q38149245-8C9B94CE-E372-431B-A629-6FDE7B0D6D0FQ38831897-5EF4EED2-DFA4-4755-8A54-42A2889830F7Q39110629-5A2A37B1-2FE2-4C9A-8616-4C7C29D59F87Q47122756-478FF481-9ECE-486C-AB99-604EE2836577Q47338470-C3BD19DF-ED11-4DBA-9341-2A005304B2AEQ49319608-0E4CF372-EFF1-48E0-AD09-C2CC368F87E8Q53300569-4F3EEB2D-82C6-47CB-8BEE-C0DE03AD275BQ57175441-D35876BA-E55A-4AB6-B495-D19FE1278C0DQ57291575-9C87D077-F644-4CC3-B6CE-EBC95D89DD98
P2860
Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@ast
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@en
type
label
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@ast
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@en
prefLabel
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@ast
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Wdr66 is a novel marker for ri ...... ageal squamous cell carcinoma.
@en
P2093
Chenming Ma
Wolfgang Kemmner
P2860
P2888
P356
10.1186/1471-2407-13-137
P407
P577
2013-03-21T00:00:00Z
P5875
P6179
1008221426